IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.079
EU - Europa 6.098
AS - Asia 3.368
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 31
SA - Sud America 21
AF - Africa 9
Totale 25.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.029
CN - Cina 2.159
UA - Ucraina 1.976
IT - Italia 1.431
DE - Germania 734
HK - Hong Kong 571
SG - Singapore 392
FI - Finlandia 379
IE - Irlanda 379
GB - Regno Unito 365
PL - Polonia 311
FR - Francia 168
IN - India 116
SE - Svezia 105
CZ - Repubblica Ceca 98
BE - Belgio 49
CA - Canada 45
TR - Turchia 34
AU - Australia 30
EU - Europa 29
IR - Iran 28
VN - Vietnam 23
NL - Olanda 16
RU - Federazione Russa 15
AT - Austria 11
CH - Svizzera 10
ES - Italia 10
HU - Ungheria 8
SA - Arabia Saudita 8
BR - Brasile 7
GR - Grecia 7
JP - Giappone 6
PH - Filippine 6
RO - Romania 6
A1 - Anonimo 5
ID - Indonesia 5
PE - Perù 5
MU - Mauritius 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
EC - Ecuador 3
PT - Portogallo 3
SI - Slovenia 3
AM - Armenia 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MS - Montserrat 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 25.641
Salva come PNG Salva come JPEG
Città #
Fairfield 2.179
Woodbridge 1.782
Jacksonville 1.536
Houston 1.299
Chandler 1.119
Ashburn 1.117
Cambridge 856
Seattle 838
Ann Arbor 807
Wilmington 781
Princeton 720
Hong Kong 564
Nanjing 507
New York 406
Dublin 375
Brescia 325
Warsaw 311
Beijing 250
Singapore 242
Helsinki 241
Nanchang 182
Des Moines 159
Dearborn 154
Milan 149
Changsha 144
Shenyang 133
Hebei 124
Lancaster 122
Jinan 121
Tianjin 118
Boardman 117
San Diego 106
Jiaxing 80
Shanghai 75
Rome 72
Brno 70
Hangzhou 60
Zhengzhou 53
Kunming 50
London 50
San Mateo 49
Munich 46
Washington 41
Los Angeles 38
Brussels 37
Ningbo 33
Norwalk 33
Toronto 32
Lanzhou 31
Augusta 30
Haikou 30
Orange 30
San Francisco 30
Guangzhou 29
Leawood 28
Taizhou 26
Olomouc 25
Verona 24
Dong Ket 22
Kocaeli 21
Monmouth Junction 18
Taiyuan 18
Fuzhou 16
Lappeenranta 16
Redwood City 16
Ardabil 15
Bologna 14
Changchun 14
Turin 14
Coventry 11
Gent 11
Kilburn 11
Palermo 11
Melbourne 10
Mumbai 10
Tehran 10
Cagliari 9
Hounslow 9
Mantova 9
Canberra 8
Cologno Monzese 8
Prescot 8
Sydney 8
Frankfurt am Main 7
Manchester 7
Poncarale 7
Bolzano 6
Hefei 6
Moscow 6
Naples 6
New Bedfont 6
Nuremberg 6
Pavia 6
Reggio Calabria 6
Reggio Nell'emilia 6
Rozzano 6
Sesto San Giovanni 6
Acton 5
Athens 5
Bitonto 5
Totale 19.405
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 442
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 257
Il training cognitivo nei pazienti affetti da schizofrenia 184
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 176
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 167
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 165
Cognitive remediation in schizophrenia: current status and future perspectives. 157
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 157
Correlates of autistic traits among patients with borderline personality disorder 152
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 145
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 141
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 139
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 138
Autism spectrum disorder and schizophrenia: Do they overlap? 137
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 136
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 134
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 130
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 130
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 129
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 129
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 127
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 126
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 125
Cognitive remediation in schizophrenia. 125
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 125
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 124
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 123
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 123
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 122
Factors Associated With Brain Heterogeneity in Schizophrenia 122
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 120
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 118
A roadmap to disentangle the molecular etiology of schizophrenia 117
Adherence to antipsychotics in schizophrenia. 117
Cognitive remediation in the early course of schizophrenia: a critical review. 115
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 114
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 113
Tools for measuring clinical effectiveness. 113
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 111
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 110
Age of onset in familial schizophrenia. 109
HLA-DR antigens in schizophrenia. 109
Season of birth and cerebral ventricular enlargement in schizophrenia 108
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 108
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 108
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 108
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 107
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 107
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 107
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 106
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 106
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 105
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 105
Autistic symptoms predict social cognitive performance in patients with schizophrenia 105
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 105
A genome-wide search for schizophrenia susceptibility genes. 104
Early life events and affective disorder revisited. 103
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 103
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 103
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 102
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 102
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 102
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 101
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 101
Il rimedio cognitivo nelle psicosi: principi e metodi. 100
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. 100
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. 99
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 99
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 98
Cognitive remediation in schizophrenia: a controlled study 98
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 98
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 98
Failure to find a chromosome 18 pericentric linkage in families with schizophrenia 97
Uso della PET e della SPECT in psichiatria 97
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 97
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 97
Language and thought disorder in schizophrenia: brain morphological correlates. 96
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 96
Cortical atrophy in schizophrenia: prevalence and associated features 96
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 96
CT scan abnormalities and outcome of chronic schizophrenia 95
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 95
Outcome of positive and negative symptoms during neuroleptic therapy in schizophrenia 95
Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. 95
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 95
Qualitative MRI findings in patients with schizophrenia: a controlled study. 93
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 93
Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia. 92
Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects. 92
CLINICAL ASSESSMENT OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA THROUGH THE SCHIZOPHRENIA COGNITION RATING SCALE: A VALIDATION STUDY IN THE ITALIAN POPULATION 92
Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. 92
Psychosocial Rehabilitation in Italy Today 92
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 92
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 91
No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia. 91
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. 91
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 91
Clinical-biological patterns and prediction of response to haloperidol in schizophrenia 91
Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. 89
Brain density patterns in schizophrenia 89
Totale 11.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.197
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.473 0 0 176 646 352 758 679 733 455 841 421 412
2020/20214.794 111 581 191 497 185 580 143 534 541 572 604 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/2025191 93 98 0 0 0 0 0 0 0 0 0 0
Totale 26.397